ArticleJournal of health economics and outcomes research2019
Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care.
W Frank Peacock et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.